Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of the number of epoetin alfa injections on hemoglobin before elective orthopedic surgery
NL-OMON45498Active, not recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of epoetin alfa and Iron in anaemia, sponsored by Sint Maartenskliniek. Primary endpoint: Increase in hemoglobin concentration between epoetin alfa injection 3 and 4. Started Nov 2017; status: active, not recruiting.
02
Drugs
epoetin alfaIron
03
Conditions
anaemia
Beyond the preview
Go deeper on NL-OMON45498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45498.